B cell lymphomas often have activating mutations in EZH2, and some subtypes of sarcomas have mutations in SWI-SNF subunits SMARCB1 (BAF47) or SMARCA4 (BRG1). This evidence concerns the gene SMARCB1 and B-cell non-Hodgkin lymphoma.